ICD
At a glance
ICD filed 48 disclosures in the last 12 months, including 12 insider, 6 contract, 2 5% holder, 1 buyback and 1 issuance. The most recent key filing was on Oct 19: Director bought 5,003 sh on the market, Oct 13–19.
Revenue for 2025 was ₩197B, up 33.5% on 2024. Operating margin was 2.3% against -18.1% a year earlier. Debt was 47% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩51.5B and operating loss of ₩3.3B.
The 2025 annual report lists 267 employees with an average tenure of 8.1 years and average pay of ₩64.4M, #788 of 1,829 listed companies by average pay. Its 5 directors and auditors were paid ₩246M each on average. It paid no cash dividend for 2025. 이승호 and related parties held 23.26% at year end.
From the 2025 annual report
Staff: 267 (248 men, 19 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩17.3B. Directors and auditors: 5, paid ₩1.2B in total.
No cash dividend was paid for 2025.
Largest shareholder
이승호 holds 14.80%; with 3 related parties the group holds 23.26% of common shares at year end (from 23.21% at the start of the year).
Auditor: 삼일 회계법인 · opinion: Unqualified.
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
Other filings
Links open the original filing on DART, in Korean.